What is lipoprotein(a)?
Lp(a) is similar to an LDL ("bad cholesterol") particle, but with an extra protein, apolipoprotein(a), attached. This extra protein makes Lp(a) more likely to build up in artery walls, promote inflammation and encourage blood clotting. The size of apolipoprotein(a) is inherited and varies widely, which is one reason Lp(a) levels range from almost undetectable to very high between individuals.
Why most people need it measured only once
Lp(a) levels are around 70โ90% genetically determined and stay fairly stable from early childhood through adult life. Diet and exercise change them very little. For that reason, European guidance recommends that every adult has Lp(a) measured at least once in their lifetime, and many other societies support testing in people at increased risk. A repeat test is usually only needed if something significant changes or if treatment specifically targets Lp(a).
Testing is particularly worth discussing if you have:
- A personal or family history of heart attack or stroke at a young age (e.g. men under 55, women under 65)
- A close relative known to have high Lp(a)
- Familial hypercholesterolaemia or very high LDL cholesterol
- Heart disease that progresses despite well-controlled LDL cholesterol
- Aortic valve stenosis
Lp(a) thresholds and what they mean
| nmol/L | mg/dL | Category | What it generally means |
|---|---|---|---|
| < 75 nmol/L | < 30 mg/dL | Risk unlikely to be raised | Lp(a) is not a meaningful contributor to risk for most people. |
| 75โ125 nmol/L | 30โ50 mg/dL | Grey zone | Possible modest contribution; interpret with other risk factors. |
| โฅ 125 nmol/L | โฅ 50 mg/dL | Raised โ risk-enhancing | Commonly used threshold for increased cardiovascular risk (e.g. AHA/ACC). |
| > 430 nmol/L | > 180 mg/dL | Very high | Lifetime risk considered comparable to familial hypercholesterolaemia in some guidance. |
These bands follow the European Atherosclerosis Society 2022 consensus statement; the โฅ 50 mg/dL (โฅ 125 nmol/L) threshold is also used by US guidance as a "risk-enhancing factor". The nmol/L and mg/dL columns are separate guideline thresholds, not conversions of each other. Labs may use different cut-offs โ read your result against the range on your report.
How Lp(a) fits with your lipid panel
A standard lipid panel measures total cholesterol, LDL, HDL and triglycerides, but not Lp(a). The cholesterol carried inside Lp(a) is, however, counted within the reported LDL cholesterol. In someone with very high Lp(a), this can make LDL look higher than it really is and can make LDL appear to respond less well to statins. Your clinician may also look at apolipoprotein B (apoB), which counts all atherogenic particles including Lp(a).
What can affect the result?
- Assay and units โ results from different methods are not always interchangeable; ideally use the same lab for any repeat.
- Kidney disease โ especially nephrotic syndrome and advanced chronic kidney disease, can raise Lp(a) (see our kidney function guide).
- Menopause โ Lp(a) tends to rise somewhat after menopause.
- Hypothyroidism โ can increase levels; see our thyroid test guide.
- Severe liver disease โ lowers Lp(a), since the liver produces it.
- Acute inflammation โ may shift levels temporarily.
Fasting is generally not required for an Lp(a) test.
What a high Lp(a) means for risk management
A high Lp(a) is a risk factor, not a diagnosis of disease. Many people with high Lp(a) never have a heart attack. The result is used to refine your overall cardiovascular risk, together with age, blood pressure, smoking, diabetes, family history and cholesterol levels. In practice, a raised Lp(a) commonly leads clinicians to:
- Manage other risk factors more intensively โ especially LDL cholesterol, blood pressure, diabetes and smoking
- Consider starting or intensifying cholesterol-lowering treatment sooner than they otherwise would
- Recommend testing of close relatives (cascade testing), since Lp(a) is inherited
- Sometimes assess the heart valves or arteries further
Statins do not lower Lp(a) and may even raise it slightly, but they remain beneficial because they reduce overall LDL-related risk. Some existing therapies (such as PCSK9 inhibitors) lower Lp(a) modestly, and lipoprotein apheresis is used in selected cases in some countries. Several medicines designed specifically to lower Lp(a) are being evaluated in large outcome trials; ask your clinician about the current evidence and availability, as this field is moving quickly.
Lifestyle measures barely change Lp(a) itself but still lower your overall cardiovascular risk, which is what ultimately matters.
When to seek urgent care
An Lp(a) result is not an emergency. However, call emergency services for chest pain or pressure, breathlessness, pain spreading to the arm, jaw or back, sudden weakness or numbness of the face or limbs, difficulty speaking, or fainting.
See your Lp(a) alongside your full cholesterol profile
Upload your blood test report to our AI analyzer โ it reads Lp(a), LDL, HDL, triglycerides and apoB against your lab's ranges, flags the units used, and explains each value in plain language.
Analyze my blood test โ